| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.26 | 4e-06 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.001 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.003 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |